Terms: = Uterine cancer AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7 AND Prognosis
3 results:
1. An organoid-based drug screening identified a menin-mll inhibitor for endometrial cancer through regulating the HIF pathway.
Chen J; Zhao L; Peng H; Dai S; Quan Y; Wang M; Wang J; Bi Z; Zheng Y; Zhou S; Liu Y; Chen C; Na F
Cancer Gene Ther; 2021 Feb; 28(1-2):112-125. PubMed ID: 32632269
[TBL] [Abstract] [Full Text] [Related]
2. Therapy-related adult acute lymphoblastic leukemia with t(4;11)(q21; q23): mll rearrangement, p53 mutation and multilineage involvement.
Bigoni R; Cuneo A; Roberti MG; Moretti S; De Angeli C; Dabusti M; Campioni D; del Senno L; Biondi A; Chaplin T; Young BD; Castoldi G
Leukemia; 1999 May; 13(5):704-7. PubMed ID: 10374873
[TBL] [Abstract] [Full Text] [Related]
3. prognosis of endometrial carcinoma stage I in two Swedish regions. A study with special regard to the effects of intracavitary irradiation with high dose-rate afterloading technique or with low dose-rate radium.
Sorbe B; Kjellgren O; Sténson S
Acta Oncol; 1990; 29(1):29-37. PubMed ID: 2310601
[TBL] [Abstract] [Full Text] [Related]
